Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kenny, A. M.
Right arrow Articles by Murrin, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kenny, A. M.
Right arrow Articles by Murrin, L. C.
NEUROLOGY 1986;36:400
© 1986 American Academy of Neurology

Bromocriptine holiday

Effects on dopamine receptors and turning behavior in rats

Anne M. Kenny, BS, Michael B. Schneider, MS, Daniel R. Baden, BS, Ronald F. Pfeiffer, MD and L. Charles Murrin, PhD

Departments of Neurology and Pharmacology, University of Nebraska Medical Center, Omaha, NE.

In experimental Parkinson's disease, we studied the effects of chronic administration (30 days), withdrawal, and reinstitution of bromocriptine. Dopamine (DA) receptor supersensitivity was produced by 6-hydroxydopamine and reversed by chronic bromocriptine administration. Drug holiday reestablished sensitivity of DA receptors, but reinstitution of bromocriptine again downregulated receptors. The effects of a drug holiday on DA receptors are shortlived, and long-term clinical improvement cannot be expected. Apomorphine-induced contralateral turning produced by the lesion was unaffected by any drug regimen.

Address correspondence and reprint requests to Dr. Pfeiffer, Department of Neurology, University of Nebraska Medical Center, 42nd and Dewey Avenue, Omaha, NE 68105.

Supported by the Frances and Edgar Reynolds Foundation and by a research fellowship from the Nebraska Medical Foundation (to A.M.K.).

Presented in part at the thirty-seventh annual meeting of the American Academy of Neurology, Dallas, TX, May 1985.

Accepted for publication July 26, 1985.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.